Articles
Circular Anastrozole Availability and Therapeutic Alternative
Aromatase Inhibitors Recommended for Breast Cancer: Tertiary & Quaternary EML Endorses Anastrozole, Letrozole & Exemestane!
The Tertiary and Quanternary Essential Medicines List (EML) recommends the use of the aromatase inhibitors for the management of adjuvant and metastic breast cancer. The aromatase inhibitors recommended are: anastrozole, letrozole and exemestane.
Click here to access the circular.